EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›DYAI

DYAI

DYADIC INTERNATIONAL INC

Next earnings Aug 11, 2026 · consensus $-0.04 EPS, $1.01M rev

Last earnings -1.4% on 2026-05-13

Avoid
$0.80
▲ +8.10%
$0.80▼ -14.61%
over 1Y
L $0.68EODHDH $1.30
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+8.1%
1W+2.1%
1M+5.4%
3M+18.0%
YTD-14.8%
1Y-14.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

Revenue fell -11.6% YoY.

Revenue (FY2025) $3.09M · FY2025

DYADIC INTERNATIONAL INC shows $3.09M in FY2025 revenue (-11.6% YoY), a -238.3% net margin, and -597.6% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$2.40M$2.93M$2.90M$3.50M$3.09M
Gross profit—————
Operating income-$14.7M-$10.2M-$8.23M-$5.90M-$7.19M
Net income-$13.1M-$9.74M-$6.80M-$5.81M-$7.36M
Diluted EPS———-$0.20-$0.23
Net margin-543.7%-332.2%-234.4%-166.2%-238.3%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$24.6M
EV / EBITDA—
EV / Sales7.9
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-25.2%
FCF yield—

Quality & risk

ROIC (est.)-461.1%
Free cash flow—
Total debt—
Net cash$4.62M
Altman Z-Score-12.47 distress
Piotroski F-Score1/7

Capital returns

Buyback yield0.0%
Dividend yield (est.)—
Shareholder yield0.0%
Shares Δ YoY+21.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — delisting notice (2026-06-18). Worth a closer look.
  1. 8-K Shareholder vote2026-06-22
  2. 8-K Delisting notice2026-06-18
  3. 8-K Reg FD disclosure2026-06-15
  4. 8-K Reg FD disclosure2026-05-28
  5. 8-K Earnings results2026-05-13
  6. 10-Q Quarterly report2026-05-13
  7. DEF 14A Proxy statement2026-05-12
  8. 10-K/A Restated periodic report2026-04-30
  9. 8-K Delisting notice2026-03-30

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-182026-06-22open ↗DEFA14AFiling2026-06-18open ↗8-KPeriod ending 2026-06-182026-06-18open ↗8-KPeriod ending 2026-06-152026-06-15open ↗8-KPeriod ending 2026-05-282026-05-28open ↗8-KPeriod ending 2026-05-132026-05-13open ↗10-QPeriod ending 2026-03-312026-05-13open ↗DEF 14APeriod ending 2026-05-122026-05-12open ↗SCHEDULE 13G/AFiling2026-05-11open ↗SCHEDULE 13GFiling2026-05-11open ↗PRE 14APeriod ending 2026-05-012026-05-01open ↗10-K/APeriod ending 2025-12-312026-04-30open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueF
GrowthF
ProfitabilityF
Financial healthD
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
Revenue
$3.09M
-11.6% YoY
Net margin
-238.3%
ROE
-597.6%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$3.09M-11.6%
Net income-$7.36M-26.8%
Operating income-$7.19M-21.9%
Diluted EPS-$0.23-15.0%
Cash & equivalents$4.62M-29.0%
Total assets$9.95M+0.2%
Total liabilities$8.71M+16.8%
Stockholders' equity$1.23M-50.1%
Op.: -232.8%L/E: 7.07x

Frequently asked

Is DYADIC INTERNATIONAL INC (DYAI) a buy?
DYAI currently carries a Avoid rating with 5/5 conviction, derived from its latest SEC filings. Revenue fell -11.6% YoY.
What is DYADIC INTERNATIONAL INC's quality score?
DYAI scores 29.745098039215684/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001213809, latest 10-Q filed 2026-05-13) · EODHD · as of 6/24/2026, 2:30:59 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-01-02
TCHELET RONEN
VP of Research and Bus. Dvlpmt
Award18.1K
2026-01-02
Rawson Ping Wang
Chief Financial Officer
Award29.2K
2026-01-02
Lucy Patrick K.
Director
Exercise21.6K
2026-01-02
Kaye Jack
Director
Exercise21.6K
2026-01-02
HERBST SETH
Director
Exercise21.6K
2026-01-02
Hazelton Joseph P
President & COO
Award36.4K
2026-01-02
EMALFARB MARK A
CEO
Award103K

Earnings history

beat/miss · move
2026-05-13Miss -22.5% est▼ -1.39%8-K ↗
2026-03-25Miss -26.4% est▲ +3.32%8-K ↗
2025-11-12Miss -35.7% est▼ -3.69%8-K ↗
2025-08-13Beat +2.0% est▼ -3.53%8-K ↗
2025-05-14—▼ -1.89%8-K ↗
2025-03-26—▼ -3.62%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial AdoptionBullish
globenewswire.com· 2026-06-15
Dyadic (DYAI) Q1 2026 Earnings Call TranscriptBullish
finance.yahoo.com· 2026-06-02
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor ConferenceBullish
globenewswire.com· 2026-05-19
Dyadic outlines cash runway into Q2 2027 while targeting mid-2026 alpha-lactalbumin samplingBullish
seekingalpha.com· 2026-05-14
Transcript: Dyadic International Q1 2026 Earnings Conference CallBullish
finance.yahoo.com· 2026-05-13
Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company ProgressBullish
globenewswire.com· 2026-05-13

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score30 vs 67
Revenue growth-11.6% vs 7.1%
Net margin-238.3% vs 10.5%
Return on equity-597.6% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 5d
Bullish
+0.17
vs typical · 7 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.